tirzepatide dose increase Dosing Tirzepatide (Mounjaro) for the Treatment
Description
Retatrutide, Lilly's potential obesity drug, shows significant weight loss and improved health in phase 2 study.
With one in eight adults taking drugs like Ozempic and Mounjaro, emerging evidence shows that the medication has potential to both help and harm people with eating disorders.
Corticosteroids can increase appetite and water retention, potentially offsetting GLP-1 medication benefits
Checkout the full interview on...
In addition, the glucagon pathway stimulation may enhance energy expenditure, contributing to greater fat-burning potential compared to traditional single-pathway peptides
